These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 996054)

  • 41. Acute and chronic LSD effects on rat startle: data supporting an LSD--rat model of schizophrenia.
    Braff DL; Geyer MA
    Biol Psychiatry; 1980 Dec; 15(6):909-16. PubMed ID: 7193055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of lysergic acid diethylamide (LSD-25) on the absolute visual threshold.
    CARLSON VR
    J Comp Physiol Psychol; 1958 Oct; 51(5):528-31. PubMed ID: 13587677
    [No Abstract]   [Full Text] [Related]  

  • 43. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.
    White FJ; Appel JB
    Science; 1982 Apr; 216(4545):535-7. PubMed ID: 7071600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD.
    Doat MM; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2003 Feb; 74(3):713-21. PubMed ID: 12543238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic intraventricular administration of lysergic acid diethylamide (LSD) affects the sensitivity of cortical cells to monocular deprivation.
    McCall MA; Tieman DG; Hirsch HV
    Brain Res; 1982 Nov; 250(2):301-8. PubMed ID: 7171990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
    Marona-Lewicka D; Thisted RA; Nichols DE
    Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.
    Kovacic B; Domino EF
    J Pharmacol Exp Ther; 1976 Jun; 197(3):495-502. PubMed ID: 1064726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subjective and EEG responses to LSD in visualizer and non-visualizer subjects.
    Brown BB
    Electroencephalogr Clin Neurophysiol; 1968 Oct; 25(4):372-9. PubMed ID: 4176542
    [No Abstract]   [Full Text] [Related]  

  • 49. Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD.
    Palumbo PA; Winter JC
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1221-6. PubMed ID: 1475306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of LSD and some analogues on the responses of single cortical neurons of the cat to optical stimulation.
    Dray A; Fox PC; Hilmy M; Somjen GG
    Brain Res; 1980 Oct; 200(1):105-21. PubMed ID: 6106524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of LSD-25 in the rat on operant approach to a visual or auditory conditioned stimulus.
    Caldwell DF; Domino EF
    Psychol Rep; 1967 Feb; 20(1):199-205. PubMed ID: 6037789
    [No Abstract]   [Full Text] [Related]  

  • 52. LSD modulates music-induced imagery via changes in parahippocampal connectivity.
    Kaelen M; Roseman L; Kahan J; Santos-Ribeiro A; Orban C; Lorenz R; Barrett FS; Bolstridge M; Williams T; Williams L; Wall MB; Feilding A; Muthukumaraswamy S; Nutt DJ; Carhart-Harris R
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1099-109. PubMed ID: 27084302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of serotonin depletion on the discriminability of LSD.
    White FJ; Simmons MA; West KB; Holohean AM; Appel JB
    Pharmacol Biochem Behav; 1980 Oct; 13(4):569-74. PubMed ID: 6449014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differences in the stimulus properties of barbital and hallucinogens.
    Hirschhorn ID; Winter JC
    Pharmacol Biochem Behav; 1975; 3(3):343-7. PubMed ID: 1153438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LSD, 5-HT (serotonin), and the evolution of a behavioral assay.
    Appel JB; West WB; Buggy J
    Neurosci Biobehav Rev; 2004 Jan; 27(8):693-701. PubMed ID: 15019419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats.
    Killinger BA; Peet MM; Baker LE
    Pharmacol Biochem Behav; 2010 Sep; 96(3):260-5. PubMed ID: 20493209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
    Pierce PA; Peroutka SJ
    J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives.
    Hoffman AJ; Nichols DE
    J Med Chem; 1985 Sep; 28(9):1252-5. PubMed ID: 4032428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ca2+ channel blockade prevents lysergic acid diethylamide-induced changes in dopamine and serotonin metabolism.
    Antkiewicz-Michaluk L; Románska I; Vetulani J
    Eur J Pharmacol; 1997 Jul; 332(1):9-14. PubMed ID: 9298920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
    Minnema DJ; Rosecrans JA
    Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.